241.58 USD
-1.33 (-0.55%)
241.58 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to NTRA. NTRA was compared to 525 industry peers in the Biotechnology industry. NTRA has a great financial health rating, but its profitability evaluates not so good. NTRA is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- NTRA had negative earnings in the past year.
- NTRA had a positive operating cash flow in the past year.
- In the past 5 years NTRA always reported negative net income.
- NTRA had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- NTRA's Return On Assets of -16.97% is fine compared to the rest of the industry. NTRA outperforms 78.10% of its industry peers.
- Looking at the Return On Equity, with a value of -24.69%, NTRA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.97% | ||
| ROE | -24.69% | ||
| ROIC | N/A |
ROA(3y)-26.97%
ROA(5y)-28.74%
ROE(3y)-50.12%
ROE(5y)-53.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 63.66%, NTRA is in the better half of the industry, outperforming 79.43% of the companies in the same industry.
- In the last couple of years the Gross Margin of NTRA has grown nicely.
- NTRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 63.66% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.09%
GM growth 5Y7.51%
2. Health
2.1 Basic Checks
- NTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NTRA has more shares outstanding
- The number of shares outstanding for NTRA has been increased compared to 5 years ago.
- Compared to 1 year ago, NTRA has an improved debt to assets ratio.
2.2 Solvency
- NTRA has an Altman-Z score of 34.16. This indicates that NTRA is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 34.16, NTRA belongs to the top of the industry, outperforming 93.71% of the companies in the same industry.
- The Debt to FCF ratio of NTRA is 0.86, which is an excellent value as it means it would take NTRA, only 0.86 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.86, NTRA belongs to the best of the industry, outperforming 94.10% of the companies in the same industry.
- A Debt/Equity ratio of 0.06 indicates that NTRA is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.06, NTRA is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
- Even though the debt/equity ratio score it not favorable for NTRA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.86 | ||
| Altman-Z | 34.16 |
ROIC/WACCN/A
WACC8.84%
2.3 Liquidity
- NTRA has a Current Ratio of 3.27. This indicates that NTRA is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 3.27, NTRA is doing worse than 61.33% of the companies in the same industry.
- NTRA has a Quick Ratio of 3.13. This indicates that NTRA is financially healthy and has no problem in meeting its short term obligations.
- NTRA's Quick ratio of 3.13 is on the low side compared to the rest of the industry. NTRA is outperformed by 60.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.27 | ||
| Quick Ratio | 3.13 |
3. Growth
3.1 Past
- NTRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.11%.
- Looking at the last year, NTRA shows a very strong growth in Revenue. The Revenue has grown by 38.17%.
- NTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 41.20% yearly.
EPS 1Y (TTM)-30.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.15%
Revenue 1Y (TTM)38.17%
Revenue growth 3Y39.47%
Revenue growth 5Y41.2%
Sales Q2Q%34.66%
3.2 Future
- The Earnings Per Share is expected to grow by 31.37% on average over the next years. This is a very strong growth
- Based on estimates for the next years, NTRA will show a very strong growth in Revenue. The Revenue will grow by 20.48% on average per year.
EPS Next Y-60.42%
EPS Next 2Y-12.26%
EPS Next 3Y22.93%
EPS Next 5Y31.37%
Revenue Next Year34.32%
Revenue Next 2Y25.32%
Revenue Next 3Y23.03%
Revenue Next 5Y20.48%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- NTRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NTRA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Price/Free Cash Flow ratio, NTRA is valued cheaper than 90.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 356.33 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- NTRA's earnings are expected to grow with 22.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.26%
EPS Next 3Y22.93%
5. Dividend
5.1 Amount
- No dividends for NTRA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NATERA INC / NTRA FAQ
What is the ChartMill fundamental rating of NATERA INC (NTRA) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NTRA.
What is the valuation status of NATERA INC (NTRA) stock?
ChartMill assigns a valuation rating of 2 / 10 to NATERA INC (NTRA). This can be considered as Overvalued.
How profitable is NATERA INC (NTRA) stock?
NATERA INC (NTRA) has a profitability rating of 2 / 10.
How financially healthy is NATERA INC?
The financial health rating of NATERA INC (NTRA) is 7 / 10.
What is the expected EPS growth for NATERA INC (NTRA) stock?
The Earnings per Share (EPS) of NATERA INC (NTRA) is expected to decline by -60.42% in the next year.